HOME >> MEDICINE >> NEWS
OneWorld Health licenses compounds from Yale, U of Washington to treat major parasitic diseases

San Francisco, Calif. July 8, 2003 -- The Institute for OneWorld Health, the first nonprofit pharmaceutical company in the United States, announced today it has licensed a novel class of high-potency compounds from Yale University and the University of Washington that could result in medicines for the developing and developed worlds.

The agreement gives OneWorld Health the exclusive license to develop the azole compounds to treat parasitic diseases in the developing world. OneWorld Health will initially focus on the use of the azoles in Chagas disease, the leading cause of heart failure in Latin America, where 16 to 18 million people are infected and another 100 million are at risk. The disease is most often transmitted by an insect known as the "kissing bug," but may also be transmitted by blood transfusion. At least 50,000 to 100,000 people in the U.S. are infected as well.

The licensing agreement also creates a dual market opportunity in which the universities could seek a pharmaceutical partner to develop the same compounds for fungal infections in industrialized countries.

OneWorld Health will conduct appropriate pre-clinical tests after selecting a lead candidate among the compounds, which represent the first new potential drugs to treat Chagas disease in decades. The compounds were developed by teams led by Andrew Hamilton, deputy provost for science and technology at Yale and professor of chemistry, in collaboration with Frederick Buckner, Michael Gelb, Wesley Van Voorhis, and Kohei Yokoyama, all professors at the University of Washington in Seattle.

"We are delighted that these potent anti-Chagas agents have been licensed to an organization that is committed to their development for treatment of this terrible parasitic disease," said Hamilton, of Yale. "We look forward to working with OneWorld Health to produce drug leads that will push these compounds into pre-clinical development and beyond."

"There is more optim
'"/>

Contact: Sedef Onder
sonder@thehaloproject.com
917-570-8934
Institute for OneWorld Health
8-Jul-2003


Page: 1 2 3

Related medicine news :

1. OneWorld Health begins final testing of drug to cure deadly kala azar in India
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. Liverpool to lead 20M Department of Health initiative to develop medicines for children
4. Health care report cards may increase racial/ethnic disparities in bypass operations
5. 2005 Behavioral Sciences & Health Services Research Award
6. Statement on the findings of the Womens Health Study
7. Bone density returns when teens stop using Depo Provera, Group Health study finds
8. Mailman School of Public Health researchers develop infectious disease diagnostic tool
9. Health initiatives can help peace building in the Middle East
10. Study naming hospitals in top 5% for clinical quality released by HealthGrades
11. RelayHealth selected by Columbia University to link doctors and patients online

Post Your Comments:
(Date:2/27/2015)... Qualis Health, one of the nation’s ... a finalist in the 6th Annual Case In ... toward continuous improvement in care transitions. The nomination ... rates through its Communities for Safer Transitions of ... this national recognition, which demonstrates Qualis Health’s dedication ...
(Date:2/27/2015)... Wausau, WI (PRWEB) February 27, 2015 ... UP4 Adult Cubes, at Natural Products Expo West, March ... “We are very excited to release the hands down ... orange cream taste with an extra zing of Vitamin ... Kids Cubes, winner of the NutrAward 2014, Delicious Living’s ...
(Date:2/27/2015)... The purpose of the Rouche Graduate ... explore the current use of 3D printing in specific ... to the Survey about 3D Printing please go to ... among large and small companies from a wide variety ... PwC and Manufacturing Institute survey of 3D Printing use ...
(Date:2/27/2015)... Marketresearchreports.biz has announced the addition of a ... market studies that presents an analysis of the global ... The research report talks about the current market trends ... industry across the globe. , According to the market ... global sports medicine devices market is likely to develop ...
(Date:2/27/2015)... 2015 Available in select spas ... http://www.lespausa.com , Phytocéane introduces ... anti-aging collection. NIGHT RENEWAL CREAM reinforces the skin’s ... tightening the facial features with a unique fomulation ... restores the Klotho youth protein which in turn ...
Breaking Medicine News(10 mins):Health News:Qualis Health Named Award Finalist for Care Transitions Work 2Health News:UAS LifeSciences to Launch UP4 Adult Cubes at Expo West 2Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 2Health News:Survey of Texas Manufacturers, Technology, Life Sciences and Innovation Companies Reveals Broad, Varied Interest and Skills Shortage in 3D Printing Applications Says NAU 3Health News:Global Sports Medicine Devices Market Benefitting from Significant Contribution from Arthroscopy Segment: MarketResearchReports.Biz 2Health News:Global Sports Medicine Devices Market Benefitting from Significant Contribution from Arthroscopy Segment: MarketResearchReports.Biz 3Health News:Phytocéane introduces NIGHT RENEWAL CREAM 2Health News:Phytocéane introduces NIGHT RENEWAL CREAM 3
(Date:2/26/2015)... 26, 2015 Every year many millions of ... heart disease.  Nevertheless, year after year doctors and the ... the first test to determine the status of heart ... or not, even though that technology is over 100 ... that doctors know, (while most patients do not know) ...
(Date:2/26/2015)... Feb. 26, 2015  Spring Bank Pharmaceuticals, Inc., ... the treatment of Hepatitis B virus (HBV) and ... a $22 million financing. Funds from this financing ... novel, broad spectrum antiviral agent derived from ... (SMNH) chemistry platform, into Phase II clinical trials ...
(Date:2/26/2015)... SOUTH SAN FRANCISCO, Calif. , Feb. 26, 2015 ... of a Series A financing round totaling $20.4 million. ... and Third Point Ventures, includes participation by Aperture Venture ... company co-founded in 2013 by David Wurtman , ... M. Scott Harris , M.D., Chief Medical Officer.  In ...
Breaking Medicine Technology:National Heart Health Month In February 2Spring Bank Pharmaceuticals Completes $22 Million Financing 2
Cached News: